Initial clinical and immunologic evaluation of a new phase I Q fever vaccine and skin test in humans.

Abstract

A new phase I Q fever skin test was administered to 74 subjects. Thirty-eight had less than 8 mm and 36 had greater than or equal to 10 mm erythema at 24 hr. Only 14 had circulating antibody. Three skin test-positive and 17 skin test-negative, seronegative individuals subsequently received 6 or 30 micrograms of vaccine in a single dose. All skin test… (More)

Topics

  • Presentations referencing similar topics